核酸 (JP Patent Analysis Report)
The Technical Field "核酸" had 31 patent application filings in the most recent period (2023-01-01 to 2023-02-28). This is a significantly decreased of -356 filings (-92.0%) over 387 they had in the same period of the previous year (2022-01-01 to 2022-02-28).
The highest number of filings in 2017 with 3,733 cases, and their lowest number in 2022 with 2,489 cases.
The mean of the number of filings over the last 5 years (2018 to 2023, 16,005 cases in total) is 2,668, and the median is 3,090. The coefficient of variation (standard deviation/mean) is 0.4, and there have been big fluctuations in the number of filings from year to year.
| Index | Value |
|---|---|
| Average | 2,668 patents |
| Std Dev | 1,180 |
| COV | 0.4 |
The number of filings has been decreasing for the last 3 years (2020 to 2023).
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 2,489 cases | -20.93 % |
| 2021 year | 3,148 cases | +3.86 % |
| 2020 year | 3,031 cases | -16.06 % |
This report provides the latest patent analysis information (the IP landscape, including a patent map) on the patent search results of the JP patent database for 核酸 for the period of the last 10 years (2014-01-01 to 2024-10-31). You can compare the information in this report with the trends in your competitors’ patent filings and technologies, and use it to search for important patents.
This service provides, free of charge, a patent analysis report based on the latest patent data (Japanese, U.S., European, and PCT application publications) for use in patent searches, patent analysis, and IP landscaping. The service is offered by "Patent Integration" a firm specializing in patent search/patent analysis.
This report includes basic information to help you understand the IP strategy and management of 核酸, such as changes in the number of patents/patent applications they have filed, comparisons of the numbers of patents/patent applications filed by their peers and competitors, their top coapplicants (joint research partners, alliance partners), and their most important patents. It can be used in various intellectual property business operations such as IP landscaping, patent search/patent analysis, preparation of intellectual property business evaluation reports, selection of M&A candidates, and selection of alliance partners.
He is a patent attorney at a patent office. He specializes in invention counseling, patent filing, and intellectual property strategies for start-up companies and new businesses in the fields of software, information technology and artificial intelligence. He runs a patent course for beginners on Udemy, an online course provider.
After studying physics at the University of Tokyo as a doctoral student, he was engaged in intellectual property analysis and technology trend research as an in-house patent attorney at a precision equipment manufacturer and at Toyota Central R&D Labs. Inc..
Introduction
The concept of the "IP landscape" (IPL) has been attracting attention recently.
An IP landscape is not limited to patent information, but also integrates and analyzes business information (e.g., non-patent information such as papers, news releases, stock information, and market information). Intellectual-property-based business management is realized through the analysis of intellectual property information applied to the formulation of management strategies and business strategies. This is a comprehensive approach that includes but not limited to planning of open and closed strategies, selecting M&A candidates, searching for alliance partners, and formulating intellectual property strategies, through the exploitation of intellectual property information.
IP landscaping usually includes patent search and patent analysis. In patent search and patent analysis, it is important to grasp the market position of each company and the overall technological trends and development trends for each technology. More specifically, it is important to understand what intellectual property your own company and other companies hold, what the strengths and weaknesses of other companies are, and how other companies are trying to exploit their intellectual property. In other words, it is important to understand both the business strategy and the intellectual property strategy of each company.
After reading this search report, you may be interested in more detailed patent searches and patent analysis. We offer a service called Patent Integration, which is an integrated patent search and patent analysis service. With reasonable pricing and a simple user interface such that even beginners can quickly search for and analyze patent information by company or technology from a web browser, please consider using it for detailed patent searches, patent analysis, and IP landscaping.
Patent Integration has a patent-landscaping function that can visually represent a set of tens of thousands of patents/patent applications. This allows you to convincingly show the technical positions of your company and its competitors to your management and business strategists in order to formulate management strategies and business strategies.
核酸, Changes in the Number of JP Patents/Patent Applications
The changes in the number of patent filings of 核酸 over the last 20 years (JP) are shown below.
The change in the number of patents/patent applications is the most basic index in patent analysis. By examining the change in the number of patents/patent applications, you can see the status of technological development and R&D focus for each company or technology. It should be noted that since there is a one and a half year lag between the filing and the laying open of patent applications, it is not possible to analyze the situation more recently than one and half years prior to the present.
In this report, you can only see the change in the number of patents/patent applications by company or technology, whereas Patent Integration allows you to quickly compare the number of patent applications with your competitors in each technical field by cross-referencing with other keywords and patent classifications.
Search Set (Analysis Patents)
This patent analysis report was created for a patent search set of 29,840 cases retrieved by applying the following search formula and analysis period to the following patent database. Patent information such as a patent analysis result, a patent map, and a patent landscape can be freely used for patent searches, analysis, and work on intellectual property strategies, including IP landscaping.
核酸
Related Patent Analysis Report
A patent aanlysis report on the following synonyms was found in the technical term "核酸".
- 核酸 (Main page / Including the following synonyms)
Same industry / competition company information (JP)
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as 核酸 are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Trends in filing of joint patent applications in the last 3 years (2022 to 2024).
Comparing the number of applications of each company, リジェネロン・ファーマシューティカルズ・インコーポレイテッド has the highest number of joint applications in the last in the last 3 years (2022 to 2024) with 47 cases, followed by ザリージェンツオブザユニバーシティオブカリフォルニア with 25 cases.
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 47 cases |
| ザリージェンツオブザユニバーシティオブカリフォルニア | 25 cases |
| エフホフマン-ラロシュアーゲー | 18 cases |
| ジェネンテックインコーポレイテッド | 15 cases |
| 東洋紡株式会社 | 13 cases |
| ザトラスティーズオブザユニバーシティオブペンシルバニア | 11 cases |
| 国立研究開発法人産業技術総合研究所 | 10 cases |
| ノバルティスアーゲー | 9 cases |
| キヤノン株式会社 | 8 cases |
| アメリカ合衆国 | 2 cases |
Trends in filing of joint patent applications for the target period (2014 to 2024).
Comparing the number of applications of each company, エフホフマン-ラロシュアーゲー has the highest number of joint applications in the last for the target period (2014 to 2024) with 446 cases, followed by リジェネロン・ファーマシューティカルズ・インコーポレイテッド with 363 cases.
| Name | Cases |
|---|---|
| エフホフマン-ラロシュアーゲー | 446 cases |
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 363 cases |
| ジェネンテックインコーポレイテッド | 355 cases |
| ザリージェンツオブザユニバーシティオブカリフォルニア | 320 cases |
| ノバルティスアーゲー | 279 cases |
| ザトラスティーズオブザユニバーシティオブペンシルバニア | 251 cases |
| 東洋紡株式会社 | 124 cases |
| アメリカ合衆国 | 104 cases |
| 国立研究開発法人産業技術総合研究所 | 100 cases |
| キヤノン株式会社 | 36 cases |
| ヒューマンジノームサイエンシーズインコーポレイテッド | 2 cases |
Same industry / competition company, Change in the Number of JP Patents
Below is a patent map showing changes in the number of applications for JP patents of 11 companies in the same industry over the past 20 years.
Top company information (JP)
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as 核酸 are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Trends in filing of joint patent applications in the last 3 years (2022 to 2024).
Among the top coapplicants, リジェネロン・ファーマシューティカルズ・インコーポレイテッド has the highest number of joint applications in the last in the last 3 years (2022 to 2024) with 47 cases, followed by ザリージェンツオブザユニバーシティオブカリフォルニア with 25 cases.
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 47 cases |
| ザリージェンツオブザユニバーシティオブカリフォルニア | 25 cases |
| エフホフマン-ラロシュアーゲー | 18 cases |
| ジェネンテックインコーポレイテッド | 15 cases |
| 東洋紡株式会社 | 13 cases |
| ノバルティスアーゲー | 9 cases |
Trends in filing of joint patent applications for the target period (2014 to 2024).
Among the top coapplicants, エフホフマン-ラロシュアーゲー has the highest number of joint applications in the last for the target period (2014 to 2024) with 446 cases, followed by リジェネロン・ファーマシューティカルズ・インコーポレイテッド with 363 cases.
| Name | Cases |
|---|---|
| エフホフマン-ラロシュアーゲー | 446 cases |
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 363 cases |
| ジェネンテックインコーポレイテッド | 355 cases |
| ザリージェンツオブザユニバーシティオブカリフォルニア | 320 cases |
| ノバルティスアーゲー | 279 cases |
| 東洋紡株式会社 | 124 cases |
| ヒューマンジノームサイエンシーズインコーポレイテッド | 2 cases |
Top company, Change in the Number of JP Patents
Below is a ranking of the number of JP patent applications by 核酸’s top 7 coapplicants over the last 20 years.
Below is a patent map showing the changes in the numbers of JP patent filings by 核酸’s top 7 coapplicants over the last 20 years.
Top company Details (JP)
Trends in filing of joint patent applications with ジェネンテックインコーポレイテッド
核酸 filed 355 joint applications with ジェネンテックインコーポレイテッド for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 115 cases in total) is 19.2, and the median is 21.5. The coefficient of variation (standard deviation/mean) is 0.6, and there have been big fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2015 with 74 cases, and their lowest number in 2020 with 13 cases.
| Index | Value |
|---|---|
| Average | 19.2 patents |
| Std Dev | 10.9 |
| COV | 0.6 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 15 cases | -48.3 % |
| 2021 year | 29 cases | +123 % |
| 2020 year | 13 cases | -53.6 % |
Trends in filing of joint patent applications with エフホフマン-ラロシュアーゲー
核酸 filed 446 joint applications with エフホフマン-ラロシュアーゲー for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 234 cases in total) is 39.0, and the median is 44.5. The coefficient of variation (standard deviation/mean) is 0.6, and there have been relatively large fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2017 with 74 cases, and their lowest number in 2022 with 18 cases.
| Index | Value |
|---|---|
| Average | 39.0 patents |
| Std Dev | 23.4 |
| COV | 0.6 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 18 cases | -60.9 % |
| 2021 year | 46 cases | +6.98 % |
| 2020 year | 43 cases | -37.7 % |
Trends in filing of joint patent applications with ザリージェンツオブザユニバーシティオブカリフォルニア
核酸 filed 320 joint applications with ザリージェンツオブザユニバーシティオブカリフォルニア for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 166 cases in total) is 27.7, and the median is 27.0. The coefficient of variation (standard deviation/mean) is 0.5, and there have been big fluctuations in the number of filings from year to year.
The highest number of filings in 2018 with 50 cases, and their lowest number in 2022 with 25 cases.
| Index | Value |
|---|---|
| Average | 27.7 patents |
| Std Dev | 15.1 |
| COV | 0.5 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 25 cases | -10.71 % |
| 2021 year | 28 cases | -24.32 % |
| 2020 year | 37 cases | +42.3 % |
Trends in filing of joint patent applications with ノバルティスアーゲー
核酸 filed 279 joint applications with ノバルティスアーゲー for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 101 cases in total) is 16.8, and the median is 14.0. The coefficient of variation (standard deviation/mean) is 0.7, and there have been relatively large fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2016 with 67 cases, and their lowest number in 2022 with 9 cases.
| Index | Value |
|---|---|
| Average | 16.8 patents |
| Std Dev | 11.9 |
| COV | 0.7 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 9 cases | -35.7 % |
| 2021 year | 14 cases | 0 |
| 2020 year | 14 cases | -50.0 % |
Trends in filing of joint patent applications with リジェネロン・ファーマシューティカルズ・インコーポレイテッド
核酸 filed 363 joint applications with リジェネロン・ファーマシューティカルズ・インコーポレイテッド for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 211 cases in total) is 35.2, and the median is 41.5. The coefficient of variation (standard deviation/mean) is 0.5, and there have been big fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2018 with 48 cases, and their lowest number in 2017 with 30 cases.
| Index | Value |
|---|---|
| Average | 35.2 patents |
| Std Dev | 16.5 |
| COV | 0.5 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 47 cases | +42.4 % |
| 2021 year | 33 cases | -25.00 % |
| 2020 year | 44 cases | +12.82 % |
Information on important patents (JP)
The following shows JP patents held by 核酸 that have had an invalidation trial against them demanded or an opposition filed against them by a third party, and 核酸’s JP patents/patent applications of high importance cited by Examiners in patent examination processes.
By noting the most important patents, you can obtain knowledge of the competitive business environment in which 核酸 is placed (e.g., whether it is a fiercely competitive environment or an oligopolistic market and the like). In general, it can be understood that a company with a large number of demands for invalidation trials is developing their business in a business environment where IP disputes are common.
If you want to search for more detailed information, you can use Patent Integration to retrieve and download by company cited patents/patent applications or patents undergoing invalidation trials. You can quickly extract important patents from a patent set that includes multiple competitors by cross-referencing with other keywords and patent classifications. Please consider using it for searches for important patents/patent applications.
Glossary
- Cited
- Indicates that the patent/patent application has been cited (by Examiners) in notices of reasons for rejection in the examination process of other (Japanese, U.S., or European) patent applications. The higher the number of citations, the more important the patent/patent application is considered to be.
- Request for invalidation trial
- Indicates that a third party has requested a procedure to invalidate the patent. It is likely to affect the business of third parties and is considered to be of high importance.
- Opposition
- Indicates that a third party has filed a petition with the Patent Office to hear the validity of the patent again. Like the trial for invalidation, it is considered to be of high importance.
- Information provision
- Indicates that a third party has provided the Patent Office with useful information for examination for the patent filed. It is usually considered to be of high importance because it is done to prevent the patent from being granted.
- Browsing request
- Indicates that a third party has requested the Patent Office to view the patent bag (a set of documents exchanged between the Patent Office and the applicant). The bag is often checked prior to trial for invalidation, opposition, and provision of information, and is considered to be a highly important patent.
Invalidationed Trial cases
List of latest Invalidationed Trial patents
In the last 3 years (2021-11-01 ~ 2024-10-31), there were 5 patents Invalidation Trial from third parties. The average number of Invalidation Trial is 1.0 times. The most recently Invalidation Trial patent is 特許6814997 "５’キャップ付ＲＮＡを合成するための組成物および方法" (Invalidation Trial day 2024-05-15) , next is 特許7016341 "ＰＤ－１軸結合アンタゴニスト及びＴＩＧＩＴ阻害剤を使用するがんの治療方法" (Invalidation Trial day 2023-03-27) .
| - | No. | Title | Invalidation Trial days |
|---|---|---|---|
| 1 | 特許6814997 | ５’キャップ付ＲＮＡを合成するための組成物および方法 | 2024-05-15 |
| 2 | 特許7016341 | ＰＤ－１軸結合アンタゴニスト及びＴＩＧＩＴ阻害剤を使用するがんの治療方法 | 2023-03-27 |
| 3 | 特許7083802 | グリコシル化された免疫グロブリンの調製方法 | 2023-02-22 |
| 4 | 特許6896700 | ワクチン組成物 | 2023-01-27 |
| 5 | 特許6692856 | ＲＮＡ依存性標的ＤＮＡ修飾およびＲＮＡ依存性転写調節のための方法および組成物 | 2022-02-25 |
Top Patents/Patent Applications with the Highest Number of Invalidationed Trial
Of the patent applications filed in the last 10 years (2014-11-01 to 2024-10-31), 3 patents/patent applications were invalidation trial more than once in the examination process of other patent applications. The mean of the number of invalidation trial is 1.3. The most invalidation trial patent is 特許5906333 "プロタンパク質コンベルターゼスブチリシンケクシン９型（ＰＣＳＫ９）に対する抗原結合タンパク質" (2 times) , and the next most invalidation trial patent is 特許6814997 "５’キャップ付ＲＮＡを合成するための組成物および方法" (1 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許5906333 | プロタンパク質コンベルターゼスブチリシンケクシン９型（ＰＣＳＫ９）に対する抗原結合タンパク質 | 2 times |
| 2 | 特許6814997 | ５’キャップ付ＲＮＡを合成するための組成物および方法 | 1 times |
| 3 | 特許6896700 | ワクチン組成物 | 1 times |
Oppositioned cases
List of latest Oppositioned patents
In the last 3 years (2021-11-01 ~ 2024-10-31), there were 19 patents Opposition from third parties. The average number of Opposition is 1.0 times. The most recently Opposition patent is 特許7433217 "ＲＮＡウイルスの処理方法" (Opposition day 2024-08-15) , next is 特許7420330 "アレルギーの抗原およびそのエピトープ" (Opposition day 2024-07-10) .
| - | No. | Title | Opposition days |
|---|---|---|---|
| 1 | 特許7433217 | ＲＮＡウイルスの処理方法 | 2024-08-15 |
| 2 | 特許7420330 | アレルギーの抗原およびそのエピトープ | 2024-07-10 |
| 3 | 特許7394749 | オリゴ核酸化合物の製造方法 | 2024-06-04 |
| 4 | 特許7448953 | 眼疾患のための細胞モデル及び治療関連出願への相互参照 | 2024-04-17 |
| 5 | 特許7244922 | 化学修飾された一本鎖ＲＮＡ編集オリゴヌクレオチド | 2023-09-20 |
| 6 | 特許7232758 | 膜透過性の高い環状ペプチド化合物、及びこれを含むライブラリ | 2023-09-05 |
| 7 | 特許7188087 | 一本鎖オリゴヌクレオチド | 2023-06-12 |
| 8 | 特許7179776 | 孵化していない卵における鳥類胚の性決定方法およびその手段 | 2023-05-24 |
| 9 | 特許7089003 | ＲＮＡの免疫原性を低減するための方法 | 2022-12-19 |
| 10 | 特許7078812 | ＲＮＡの免疫原性を低減するための方法 | 2022-12-01 |
Protested cases
List of latest Protested patents
In the last 3 years (2021-11-01 ~ 2024-10-31), there were 50 patents Protest from third parties. The average number of Protest is 1.2 times. The most recently Protest patent is 特表2023-517644 "コロナウイルスワクチン組成物及び方法" (Protest day 2024-06-15) , next is 特表2022-531876 "オリゴヌクレオチドの収束液相合成" (Protest day 2024-05-09) .
| - | No. | Title | Protest days |
|---|---|---|---|
| 1 | 特表2023-517644 | コロナウイルスワクチン組成物及び方法 | 2024-06-15 |
| 2 | 特表2022-531876 | オリゴヌクレオチドの収束液相合成 | 2024-05-09 |
| 3 | 再公表2019/050017 | バイオチップ用基体、バイオチップ、バイオチップの製造方法およびその保存方法 | 2024-04-22 |
| 4 | 特許7545478 | 環状ジペプチド、プリンヌクレオチド及び／又はアミノ酸とチキンエキスとを含む組成物、その製造方法、並びに、環状ジペプチド、プリンヌクレオチド及び／又はアミノ酸、並びにチキンエキスの使用 | 2024-03-25 |
| 5 | 特表2022-518510 | 薬物耐性ＭＹＣＯＰＬＡＳＭＡ ＧＥＮＩＴＡＬＩＵＭの検出 | 2024-03-13 |
| 6 | 特許7479635 | γδＴ細胞の製造方法 | 2024-02-19 |
| 7 | 特開2023-052694 | 悪臭調節化合物の同定方法 | 2024-02-17 |
| 8 | 特表2023-544184 | 接着細胞からのウイルスのバイオリアクター生成 | 2024-02-01 |
| 9 | 特許7550225 | 溶液工程でのＰＮＡオリゴマーの製造方法 | 2024-01-19 |
| 10 | 特表2023-531816 | 新規なアテロコラーゲンおよびその用途 | 2023-12-13 |
| 11 | 特許7532752 | 改良されたウイルス検出方法 | 2023-11-06 |
| 12 | 特許7516731 | 改良されたウイルス検出方法 | 2023-11-06 |
| 13 | 特許7438604 | ＳＡＲＳ－ＣＯＶ－２ ｍＲＮＡドメインワクチン | 2023-10-27 |
| 14 | 特許7537422 | 相補部分を含む修飾オリゴヌクレオチドの製造方法 | 2023-08-15 |
| 15 | 特許7433217 | ＲＮＡウイルスの処理方法 | 2023-08-08 |
| 16 | 特許7392309 | 改良されたウイルス検出方法 | 2023-07-25 |
| 17 | 特表2021-503278 | ＣａｓＺ組成物及び使用方法 | 2023-07-06 |
| 18 | 特表2021-505171 | 噴霧乾燥シアリルラクトース | 2023-06-14 |
| 19 | 特表2020-528280 | シアリルトランスフェラーゼ及びシアリル化オリゴ糖の生産におけるその使用 | 2023-05-26 |
| 20 | 特表2021-520399 | ポリソルベートを使用するポリペプチドの精製方法 | 2023-03-31 |
Top Patents/Patent Applications with the Highest Number of Protested
Of the patent applications filed in the last 10 years (2014-11-01 to 2024-10-31), 98 patents/patent applications were protest more than once in the examination process of other patent applications. The mean of the number of protest is 1.3. The most protest patent is 特開2017-061467 "血管新生眼疾患を処置するためのＶＥＧＦアンタゴニストの使用" (5 times) , and the next most protest patent is 特開2019-167366 "血管新生眼疾患を処置するためのＶＥＧＦアンタゴニストの使用" (4 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特開2017-061467 | 血管新生眼疾患を処置するためのＶＥＧＦアンタゴニストの使用 | 5 times |
| 2 | 特開2019-167366 | 血管新生眼疾患を処置するためのＶＥＧＦアンタゴニストの使用 | 4 times |
| 3 | 特開2019-193655 | カチオンキレーターホットスタート | 3 times |
| 4 | 特許6752724 | 球状多孔質ヒドロキシアパタイト吸着剤及びその方法 | 3 times |
| 5 | 再公表2019/050017 | バイオチップ用基体、バイオチップ、バイオチップの製造方法およびその保存方法 | 3 times |
Inspectioned cases
List of latest Inspectioned patents
In the last 3 years (2021-11-01 ~ 2024-10-31), there were 438 patents Inspection from third parties. The average number of Inspection is 1.2 times. The most recently Inspection patent is 特表2021-517895 "ＨＰＶ関連疾患を処置するための方法" (Inspection day 2024-09-19) , next is 特表2021-502097 "標的化ＣＲＩＳＰＲ送達プラットフォーム" (Inspection day 2024-09-17) .
| - | No. | Title | Inspection days |
|---|---|---|---|
| 1 | 特表2021-517895 | ＨＰＶ関連疾患を処置するための方法 | 2024-09-19 |
| 2 | 特表2021-502097 | 標的化ＣＲＩＳＰＲ送達プラットフォーム | 2024-09-17 |
| 3 | 特表2023-517644 | コロナウイルスワクチン組成物及び方法 | 2024-09-13 |
| 4 | 特表2021-520399 | ポリソルベートを使用するポリペプチドの精製方法 | 2024-09-12 |
| 5 | 特表2022-543236 | エクソン４４標的化核酸およびジストロフィンベースのミオパチーの治療のための当該核酸を含む組換えアデノ随伴ウイルス | 2024-09-12 |
| 6 | 特表2021-530212 | レトロトランスポゾンベースの送達媒体及びその使用方法 | 2024-09-10 |
| 7 | 特許6738314 | ＢＣＭＡおよびＣＤ３に対する結合分子 | 2024-09-10 |
| 8 | 特表2022-500042 | 抗ＨＩＶ抗体１０−１０７４バリアント | 2024-09-06 |
| 9 | 特表2024-532019 | アルファ－１アンチトリプシン発現を阻害するための組成物及び方法 | 2024-09-06 |
| 10 | 特表2021-531022 | 環状ポリリボヌクレオチドを含む組成物及びその使用 | 2024-09-06 |
| 11 | 特表2022-537670 | ＣＡ２の組成物および調整可能な制御方法 | 2024-09-05 |
| 12 | 特表2021-521798 | がんに対する組換え型の治療介入 | 2024-09-02 |
| 13 | 特表2022-527763 | 修飾環状ポリリボヌクレオチドを含む組成物及びその使用 | 2024-08-30 |
| 14 | 特表2021-518160 | 免疫療法の改善のための遺伝子調節組成物及び遺伝子調節方法 | 2024-08-29 |
| 15 | 特開2023-002670 | 認知障害を治療または予防するためのヒト化抗体、その製造プロセス、及びそれを用いた認知障害を治療または予防するための薬剤 | 2024-08-23 |
| 16 | 特表2021-525515 | 複数種の核酸試料を処理または分析するための組成物、方法およびシステム | 2024-08-22 |
| 17 | 特表2024-511415 | 神経系障害の標的に方向づけられた機能性核酸分子 | 2024-08-21 |
| 18 | 特許6953586 | 患者検体の核酸配列の解析方法、解析結果の提示方法、提示装置、提示プログラム、及び患者検体の核酸配列の解析システム | 2024-08-20 |
| 19 | 特許7526049 | 患者検体の核酸配列の解析方法、解析結果の提示方法、提示装置、提示プログラム、及び患者検体の核酸配列の解析システム | 2024-08-20 |
| 20 | 特表2023-542529 | 修飾された機能性核酸分子 | 2024-08-19 |
Top Patents/Patent Applications with the Highest Number of Inspectioned
Of the patent applications filed in the last 10 years (2014-11-01 to 2024-10-31), 855 patents/patent applications were inspection more than once in the examination process of other patent applications. The mean of the number of inspection is 1.2. The most inspection patent is 特開2019-167366 "血管新生眼疾患を処置するためのＶＥＧＦアンタゴニストの使用" (10 times) , and the next most inspection patent is 特開2017-061467 "血管新生眼疾患を処置するためのＶＥＧＦアンタゴニストの使用" (8 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特開2019-167366 | 血管新生眼疾患を処置するためのＶＥＧＦアンタゴニストの使用 | 10 times |
| 2 | 特開2017-061467 | 血管新生眼疾患を処置するためのＶＥＧＦアンタゴニストの使用 | 8 times |
| 3 | 特開2017-046722 | ヒト化軽鎖マウス | 8 times |
| 4 | 特開2016-144451 | より新規形態の干渉ＲＮＡ分子 | 7 times |
| 5 | 特許6426670 | 真核生物細胞を改変する方法 | 6 times |
Cited cases
Top Patents/Patent Applications with the Highest Number of Cited
Of the patent applications filed in the last 10 years (2014-11-01 to 2024-10-31), 3,518 patents/patent applications were cited more than once in the examination process of other patent applications. The mean of the number of cited is 2.3. The most cited patent is 特許7185009 "細胞トランスフェクションのエレクトロポレーション装置及び方法" (39 times) , and the next most cited patent is 特許6232009 "ＣＤＲのアミノ酸置換により抗体の等電点を改変する方法" (39 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許7185009 | 細胞トランスフェクションのエレクトロポレーション装置及び方法 | 39 times |
| 2 | 特許6232009 | ＣＤＲのアミノ酸置換により抗体の等電点を改変する方法 | 39 times |
| 3 | 特表2017-500035 | 遺伝子編集用のＣＡＳ多様体 | 26 times |
| 4 | 特許7023465 | 検体中の細菌数の定量方法 | 24 times |
| 5 | 特許6375329 | ベロ細胞において増強された複製を有する高力価の組換えインフルエンザウイルス | 23 times |
Providing patent information to the media (newspapers, magazines, etc.)
"Patent Integration Report" is a web service provided by "Patent Integration Co., Ltd." operated by patent attorneys who are experts in intellectual property rights. Based on the latest patent data, this is one of the largest patent report services in Japan that provides information on technology trends in various companies and technology fields.
The purpose of this web service is to make intellectual property information familiar to many people, regardless of whether they have an interest in intellectual property rights, and to make use of it.
We actively provide various types of patent information that can be used in various media articles such as newspapers, magazines, and web media. Please feel free to contact us from "Inquiry form for details on the content of patent information that can be provided, conditions for provision, etc. Please contact us.
About this Site
All rights related to the data, documents and charts belong to "an integrated patent search/analysis service provider, Patent Integration". Please specify the source “Patent Integration Report, URL: https://patent-i.com/report/en/" when inserting them into in-house materials, external report materials, etc., regardless of whether they are paid or free of charge.
Patent data is obtained by aggregating and analyzing the latest patent data issued by the Patent Offices of respective countries and jurisdictions and by WIPO. Although we take great care in publishing and analyzing the results, we do not guarantee the correctness of the data. We appreciate your understanding.
If you have any concerns about this service, please feel free to contact us.
All rights to the data, documents, figures and tables are reserved by e-Patent. When publishing internal documents, external reports, etc. (whether paid or free of charge), please use the following URL: https://e-patent.co.jp/.
Please note the following points for use.
e-Patent will not be liable for any damages or losses arising from the use of the global patent application status, ranking information, or population search formula in the "SDGs Global Company Ranking from a Patent Perspective". Items with ● in front of the target are not supported at this time (judged to be difficult to approach from the patent information analysis).
Citation of patent application status and ranking information
There is no problem to cite patent application status and ranking information, but please clearly indicate "Source: e-Patent Co.
Graphs are image data.
Please note that the various graphs are image data, but we cannot provide them in text data.Scope of coverage for each goal/target
- Based on the description of each goal and target of the SDGs, we have set the scope of technologies to be covered based on our and e-Patent's past experience, etc. (in some cases, the search is based on social issues themselves). Therefore, please note that there is a possibility that this "SDGs Global Company Ranking from Patent Perspective" may not cover 100%.
- A population search formula is clearly indicated for each goal/target (database: Patent Integration). You may use the population search formula as it is, or you may improve it by yourself.
- This search covers patents and utility models, including both published and registered patents (design and design patents are excluded). The unit of count is the number of applications, not the number of patent families.
About the name collation and name control of applicants and right holders
- Company rankings are based on the results calculated by "Patent Integration", with Japanese organizations in Japanese and other companies in English (some are in Japanese).
- Company names may be the names of the companies at the time of application, but the results calculated by Patent Integration are used as is. Company names are used as they were at the time of application.
- Because of the fluctuation in the names of companies (i.e., applicant/right holder names in the patent information), there are cases where the same company appears more than once in the top 10. The number of applications filed by the same company in the top 10 is the total number of applications filed by the company.
Credit notation
・MeCab user dictionary for science technology term © National Bioscience Database Center licensed under CC Attribution-Share Alike 4.0 International
Our Commitment to Safety and Security
Patent Integration Co., Ltd. is committed to providing high-quality patent information based on the latest patent data on more than 45 million cases collected from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publication. 
Patent Integration Co., Ltd. collects the patent data from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publications to provide it widely in the form of reports so that anyone can check patent information and patent trends with confidence. 
Patent Integration Co., Ltd. is committed to various efforts to enhance the reliability of the information and to allow users to search patent information with confidence.